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Dimethylformamide dimethylacetal (DMFDMA, dimethoxy​methyl​dimethylamine, 1a, Figure 1) is a con​venient electrophile to introduce one-carbon units at the formate oxid​at​ion level.1 Con​densation with prim​ary amines and amides leads to N,N-di​meth​yl​form​am​id​ines and N’-acyl-N,N-dimethyl​form​am​ides, res​p​ec​tively;2 the latter can be cyclised to 1,2,4-tri​azoles with hyd​ra​z​ines and to 1,3,5-tri​azines with guan​id​ines.3 Methyl anth​ranilate con​denses with 1a to give methyl 2-(di​methyl​form​amid​ino)​benz​oate, which, on treat​ment with prim​ary amines, fur​n​ishes 3-alkyl​quin​az​olin-4-ones.4 It also con​denses with “active” meth​ylene groups to form N,N-di​meth​yl​enamines. These enamines are ex​cel​lent alde​hyde equiv​al​ents in further synthesis, part​ic​ul​arly of a wide range of het​er​o​cycles. For example, aceto​phen​ones con​dense with 1a to give 3-di​meth​yl​amino​prop​enoyl​ben​z​enes; these con​jugate elec​tro​philes react with guan​id​ines to form 4-aryl​pyr​im​id​ine-2-amines1 and with aryl​hyd​razines to form 1,4-diaryl​pyr​azoles.5 Con​den​s​at​ion of 1a with methyl groups on elec​t​ron-def​ic​ient arom​atic rings is also efficient and pro​duces 2-aryl​en​amines; again these are use​ful syn​th​etic equiv​al​ents of aryl​acet​alde​hydes. The Ar-Me is part​ic​ul​arly act​iv​ated in methyl 2-methyl-3-nitro​ben​zoate and con​den​s​ation with 1a gives an enamine. Pass​age of this inter​med​iate through a moist silica gel col​umn hydro​lyses the enamine and cyc​lises to 5-nitro​iso​coum​arin, a key inter​med​iate in the syn​th​esis of 5-amino​iso​quin​olin-1-one,6 an im​por​tant in​hib​itor of poly​(ADP-ribose)​poly​mer​ases-1 and ‑2.7 This pro​cess cannot be ex​ten​ded, as con​den​s​at​ion of the star​ting ester with 1d gen​er​ates an alter​n​at​ive en​amine, leading to 3-di​meth​yl​amino-1-meth​oxy-5-nitro​naph​th​al​ene.8 By contrast, reac​tions of 1 where the elec​tro​philic centre is one of the methyl groups are virtually un​known; the form​at​ion of methyl esters from carb​ox​ylic acids is actually an in​cor​por​ation of a nuc​leo​philic MeO unit. 
	Synthetic approaches to quinazolin-4-ones lacking C2- and N3-sub​stituents have mostly in​vol​ved the intro​duction of the 2-C as a one-carbon electro​phile to anthranilamides, although 1a appears not to have been used for this purpose. The principal method is to heat the anthranilic acid to high tem​p​er​at​ures (>180C) with form​amide.9,10 These quin​az​ol​in-4-ones can then be readily alk​yl​ated at 3-N with alkyl halides and potass​ium hyd​r​oxide in meth​anol11 or under phase-trans​fer conditions.10 Less-used routes to N3-alkylquinazolin-4-ones inc​lude replace​ment of the whole [N3-Ar] unit of 3-(2-cyano​phenyl)​quinazolin-4-ones with primary alkyl​amines (by initial nucleo​philic attack on the carbonyl),12 copper(I)-catalysed reac​tion of N-alkyl-2-iodo​benz​amides with form​amidine,13 photochemical rearrange​ments of 2-alkyl​cinnol​inium-4-olates14 and condensation of anth​r​anilic acid with prim​ary amines and ortho​esters under Lewis acid catalysis15,16 and with alkyl​isocyanides.17 The way is therefore open to examine whether 1a and its homologues can be used as a source of electro​philic one-car​bon units to con​vert anthranilamides to 3-un​sub​s​t​it​uted quin​azolin-4-ones under milder con​dit​ions than required for the cor​responding reac​tion with form​amide; this study also inc​luded the effect of a diversity of substituents at the 3-pos​it​ion of the anthr​anilamide to test sen​sit​ivity to steric bulk ortho to the amine and to electron-with​drawing or electron-donating substit​uents which influence the nuc​leo​philicity of this amine.
Results and discussion
In an initial experiment (Scheme 1), heating anthranilamide 7 with three molar equiv​al​ents of 1a in DMF at reflux for a short period (90 min) gave the expected quinazolin-4-one 19a in 75% yield; in this process, the orthoamide 1a is acting purely as a source of the 2-CH unit at the formate oxid​ation level. However, during purification, the material had to be separated from a less-polar con​taminating product. Repeating the treatment of 7 with 1a but for a longer time (16 h) led to com​plete consumption of the desired 19a and con​version to the less-polar mat​er​ial, which was iso​lat​ed in 95% yield. This was isolated and characterised by 1H NMR spec​troscopy as an N-meth​yl​quin​az​olin-4-one or as 4-meth​oxy​quinazoline, with the obser​vation of a signal integrating for three protons at  3.48. The structure was confirmed as 3-methyl​quinazolin-4-one 26a by com​par​is​on with lit​erature mp data11 and by HMBC correl​at​ions between the methyl 1H NMR signal at  3.48 and the 2-C signal at  148.41 and between the methyl protons and the 4-C signal at  160.64. The 13C NMR spec​trum had been prev​ious​ly assigned by reference to the 1H spec​trum using HSQC and HMBC data. The alternative struc​tures 1-methyl​quin​azolin-4-one and 1-meth​oxy​quin​azoline were incon​sistent with these HMBC data. Thus 26a appeared to arise from methyl​ation of 19a at N3.
The question then arises as to the source and nature of the elec​tro​philic methylating agent; does the methyl group come from O-Me or from N-Me of 1a? This was addressed by rep​eating the con​densation with the corresponding O-Et reagent, di​meth​yl​form​amide di​ethyl​acetal (DMFDEA, 1b). Reaction of 7 with 1b in boiling DMF for 16 h led to the formation of the N3-ethyl​quin​az​ol​in-4-one 26b but in the lower yield of 52%. Thus it is clear that, with simple alkyl groups, the alkyl group introduced at N3 arises from the O-alkyl groups in the reagent orthoamide and not from the N-alkyl groups.
Since our medicinal chemical interest is in quinazolinones related to 19-25, i.e. with an 8-sub​stit​uent, the effect of sub​stit​ut​ion at pos​ition-3 of the anthranilamide on the cyclo​con​den​s​ation to the quin​az​olin-4-ones and on the new N3-alkylation of the put​at​ive inter​mediate 8-substituted quin​azolin-4-ones was inves​t​ig​ated. The substituents at the 3-position of the anthranilamides were chosen to be diverse in elec​tr​onic effect, to explore the scope fully, ranging from the strongly electron-with​drawing nitro group in 8 to the electron-donating methoxy group in 10, through a small alkyl in 9, a halo​gen in 11 and an ester in 12. The anthra​nil​amides 8-12 were not com​mer​cially available but were syn​th​es​ised from their cor​res​ponding benz​oic acids 2-6, as shown in Scheme 1. 3-Nitro​anth​ranilic acid 2 was treated with thio​nyl chlo​r​ide, foll​owed by amm​o​nia to give 8, presumably via a benz​​oxa​thiazine-2,4-dione inter​mediate. This method failed for reac​tions of 3-6 but treat​ment with these anth​ranilic acids with 1,1’-car​bonyl di​imid​azole at elevated temp​er​ature, followed by react​ion of the inter​mediate (an N-acyl​imidazole or an isa​toic an​hyd​ride) with amm​onia furn​ish​ed the anthranilamides 9-12 for the study. As for the par​ent anth​ranilamide 7, treat​ment of 8-12 with ex​cess 1a in refluxing DMF for 16 h furn​ished the cor​res​p​on​d​ing N3-methyl​quin​azolin-4-ones 27a,28a,29a,30a,31a in very high yields. Sim​ilar react​ions of 8-11 with 1b gave the N3-ethyl​quin​az​ol​in-4-ones 27b,28b,29b,30b but gen​er​ally in lower yields. The reac​tion of the methyl ester 12 with 1b gave the ethyl ester 32b, through trans​ester​if​ic​ation with eth​an​ol gen​er​ated as a leaving group from the ortho​amide during the con​den​sation. The loc​at​ion of the new alkyl group at N3 was con​firmed in each case by HMBC correl​at​ion spectra.
Extending the scope of the new reaction to larger primary alkyl groups, heating 7-10 with the di​benz​yl orthoamide 1c gave the N-benzyl​quinazolin-4-ones 26c,27c,28c,29c, gener​ally in good yields, except for the nitro analogue 27c. The condensation / alkyl​ation can also be exten​ded to intro​de a alkyl substituent at the 2-posit​ion, which would require an acet​amide acetal, rather than the form​amide acetals used hitherto. Reaction of the anth​r​anil​amides 7-10 with di​methyl​acet​amide di​methyl​acetal 1d in boiling DMF gave mod​er​​ate yields of the 2,3-dimethyl​quin​az​ol​in-4-ones 26d,27d,28d,29d. 
In each run with orthoformamides 1a-c, formation of the inter​med​iate quinazolin-4-ones 19a,21a,22a,23a was detected by TLC at shorter time periods but no 8-nitroquinazolin-4-one 20a was ob​served. This anomalous behav​iour of the compounds con​t​ain​ing the nitro group led to a study of the reac​t​ion of 8 with 1a under milder con​ditions. Heating 8 with 1.2 molar equiv​al​ents of 1a in boil​ing THF (ca. 65C, cf. 150C for refluxing DMF) gave a solid which was shown by 1H and 13C NMR spectroscopy to com​prise a mix​ture of the acyl​form​am​idine 33, with smaller amounts of 20a and 27a (Scheme 1). This experiment gives sig​nif​ic​ant insights into the course and mechanism of the con​den​s​at​ion forming the quin​az​ol​in​one heterocycle and the alkyl​at​ion at N3.
Scheme 2 shows our proposal for the mechanisms of these novel processes with ortho​amides 1a-d carrying primary O-alkyl groups. Thermal elim​in​ation of methoxide from 1a-d generates the alk​oxyiminium ion 34. In the parent anthr​anilamide 7 and in 9-11, which lack electron-withdrawing subst​it​uents at the 3-pos​it​ion ortho to the aniline NH2, this ArNH2 is the more nuc​leo​philic of the two nitro​gens and attacks the sp2-carbon of 34 to give tetra​hed​ral inter​mediates 35-40. Another elim​in​at​ion of meth​oxide leads to formamidine inter​mediates 13-18, where the sp2 carbon is again the elec​tro​phile in the intra​mol​ec​ular reaction with the primary amide. Simple elimination of di​methyl​amine from the sec​ond tetra​hedral inter​mediates 41-46 gives the quin​az​olin-4-ones 19,21-25. The ortho​amides 1 are basic and generate some of the cor​res​ponding anion. This quinazolin-4-one anion then attacks the cationic inter​med​iate 34 at the O-alkyl group. This SN2-like sub​stit​ut​ion is fac​il​itated by DMF being an excel​lent leav​ing group. Thus the alk​oxy​iminium 34 can be electrophilic either at the cen​tral sp2 car​bon or at the sp3 carbon of the O-alkyl group. The observ​ation that 19a can be iso​lated at short reaction times and that 21a,22a,23a,24a can be seen by TLC in the reac​tion mix​tures of longer treatment of 7,9-12 with 1a confirms that the methylation occurs after the form​ation of the quinazolin-4-one ring and is, therefore, slower than the cyclo​con​den​s​at​ion step. The ethylation reactions are gen​er​ally slower and lower-yielding than the meth​yl​ations, con​sistent with steric crowding at the CH2 group of the eth​oxy​iminium inter​med​iate 34b. No effect of the elec​t​ronic nature (elec​tron-don​at​ing, elec​tron-neutral) of the 3-sub​st​it​uent in 7,9-12 is seen in the out​come of the reaction.
The situation is different for the com​pounds bearing the elec​tron-with​drawing nitro group. Heating 8 with 1a at lower tem​p​erature allowed 33 to be isolated as an inter​med​iate, whereas no form​amidine could be iso​lated in the reaction of 7 with 1a in boil​ing THF. This indicates that the nitro group de​act​iv​ates the ortho-amine to such an extent that the amide-NH2 be​comes the more nuc​leophilic of the two NH2 nitro​gens. Con​den​s​ation of 8 with 34 thus proceeds via attack of the weak​ly nuc​leophilic amide NH2 at the sp2 elec​tro​philic centre. The tetra​hed​ral inter​mediate 35 then col​lapses to form the acyl​form​am​id​ine 33, which cyclises to form 20a. Sub​se​quent meth​yl​at​ion forms 27a. Two further exper​im​en​tal obser​vations are pert​in​ent. Firstly, 33 is unstable to col​umn chrom​ato​graphy, retur​ning to 8 rather than cyclising to 20a; this is con​sis​tent with the very low intra​mol​ec​ular nucleo​philicity of the ad​jac​ent 2-NH2, with inter​mol​ec​ular silica-bound water being more reac​tive. Secondly, 20a was not shown as an inter​med​iate by TLC (com​parison with auth​en​tic stan​dard prepared from 2 and form​amide) at any stage of the two-step reaction at 150C. It was obs​er​ved as a minor com​pon​ent of the mixture of products of react​ion of 8 with limit​ing amount of 1a at lower temper​ature. At the higher temper​ature with excess 1a, it is clear that the cyc​lo​con​d​en​sation reac​tion is slow​ed sig​nif​ic​antly by the nitro group, such that the meth​yl​ation (and, indeed, ethyl​ation) reac​tions are now faster and inter​med​​iate 20a is consumed as soon as it is formed. With only 1.2 equiv​alents of 1a and the lower tem​p​erature, the supply of bi​fun​c​tional elec​tro​phile 34a is exhausted, as form​ation of 26a requires two equiv​alents thereof.
In contrast to the N3-alkylations observed with orthoamides carry​ing unhindered primary alkoxy groups, Scheme 3 shows the anom​alous products obtained from reactions of the anth​r​anil​amides 7-10 with orthoamides 1e-g, carrying isopropoxy (sec​ond​ary), t-butyl (tertiary) and neo​pentyloxy (hindered primary) groups, respectively. Reaction of anthranilamides 7,9,10 with 1e at 150C for 24 h gave mixtures which were not chromato​graph​ic​ally separable but which were analysed by 1H and 13C NMR. The component compounds were further identified by COSY, NOESY, HSQC and HMBC NMR and MS. A component of each mix​ture was the corres​ponding N3-un​sub​st​it​uted quinazolin-4-one 19a,21a,22a. Also observed were the expected N3-iso​prop​yl​quin​az​olin-4-ones 26e,28e,29e. The location of the isopropyl group at the 3-pos​it​ion in 26e,28e,29e was con​firmed for each exam​ple through HMBC cross-peaks connecting the iso​propyl 2-H with 2-C and 4-C of the quin​az​ol​in-4-one and by NOE between 2-H and the iso​propyl (CH3)2 and isopropyl CH protons. Less ex​pected was the form​at​ion of the 4-iso​prop​oxy​quin​azolines 47e,49e,50e by alkylation at the harder nuc​leo​phile oxygen. Isomers 26e,28e, 29e and 47e,49e,50e were formed in approx​imately equi​molar amounts in each case. The struc​tures of 47e,49e,50e were con​fir​med by the more down​field 1H chemical shifts of the iso​propyl central protons  5.43-5.58) and the 13C chem​ical shifts of the iso​pro​pyl central car​bons ( 69.84-70.01), com​par​ed to the cor​res​pon​ding values for 26e,28e,29e (1H  4.97-5.03; 13C  45.09-46.19). For 49e, an HMBC cross-peak was observed con​nec​ting the iso​propyl 2-H with the quin​az​oline 4-C. More un​ex​p​ected was the presence of the corresponding N3-methylquin​az​ol​in-4-ones 26a,28a,29a as the major com​pon​ents of the product mix​tures. Similar reac​tion of the nitro anal​ogue 8 with 1e, followed by very careful chrom​at​o​graphy, gave only a very small pure sample of 27e.
Moving from the moderate steric demand of the isopropyl group to the severe crowd​ing of the t-butyl unit, 7 was treated with five equivalents of 1f at 150C for 24 h; this process fur​nish​ed only the N3-unsubstituted quinazolin-4-one 19a, in high yield. When 19a was re-sub​jected to the same reaction con​dit​ions with a fur​ther five equivalents of 1f for a fur​ther 24 h, chrom​at​o​graphy of the prod​uct mixture provided very small amounts of N3-But-quin​azolin-4-one 26f and 4-ButO-quinazoline 47f, along with major recovery of unreacted 19a. Although 1g contains primary alk​oxy groups, these are neo​pentyl, which should preclude both SN1-like and SN2-like electrophilic react​ions. Treatment of 7 with 1g afforded good yields of 19a and, unexpectedly, the N3-methylquin​azolin-4-one 26a.
Scheme 4 provides our mechanistic rat​ion​ale for these unusual ob​servations. Inter​mediate cation 34e is generated by elimination of iso​prop​an​ol from 1e. The quinazolinone anion can be rep​res​en​ted in two mesomeric struc​t​ures, 19A-22A and 19B-22B, show​ing that it has two pot​en​t​ially nucleophilic sites. When this meets simple pri​m​ary alkoxy elec​tro​philes 34a-d, alkylation takes place exc​l​us​ive​ly at the softer and more nucleophilic nitrogen. How​ever, the increased steric bulk of the sec​on​d​ary alkyl group drives some of the alkylation to the more sterically access​ible but more weakly nucleophilic oxygen, giving the 4-iso​prop​oxy​quin​az​ol​ines 47e-50e, in addition to the N-alkyl​ated products 26e-29e. The secondary alkyl electrophile in 34e may also be more “SN1-like” / cationic in its reactivity, making it a harder electrophile with greater propensity to react at oxygen, whereas the corresponding primary alkyl intermediates 34a-d may be more “SN2-like” and softer in their electrophilic reactivity, reacting only with the softer nitro​gen nucleophile. However, both reac​tions are slow, diverting the nucleo​philes 19A-22A to app​roach the alternative elec​tro​philic site in 34e, the in​t​rin​sically less electro​philic but less sterically en​cum​bered N-methyl. This pro​cess generates an imino​ester as the leaving group, in form​ing the 3-methyl​quin​az​ol​in-4-ones 26a-29a. The steric bulk is in​cr​ea​sed fur​ther in inter​med​iate cation 34g. This can form readily by ther​mal elim​ination of neo​pentyl alcohol from 1g but the rem​aining neo​pen​tyl alkyl group at the oxy​gen cannot react as an alk​yl​at​ing elec​trophile, either by SN1 or SN2 mech​anisms. Thus the only elec​tro​philic site in 34g is the N-methyl, which alkylates anion 19Aa to form 26a. Intermediate 34f, derived by elim​ination of ButOH from ortho​amide 1f, may, at first sight, be expec​ted to behave like intermediate cation 34g and thus condense with 7 to give 19a, which would then be meth​yl​ated by the weak N-Me elec​t​rophile to give 26a. However, by far the major pro​d​uct is 19a, with traces of the N-But and O-But com​pounds 26f and 47f, with no N-meth​ylation. This observ​at​ion can be rationalised, as cationic inter​mediate 34f has an alternative mode of decomp​osition through an elim​ination giving 2-methyl​prop​ene and DMF (Scheme 4). The life​time of 34f at 150C may be long enough to insert 2-C of the quin​azoline, a rapid reaction at this tem​p​erature, but too short to allow it to per​sist long enough to carry out the slow methylation using the N-methyl groups. Interestingly, the tertiary alkyl group of 34f should react in an “SN1-like” manner, allowing it to alkyl​ate the harder oxygen as well as the softer nitrogen nucleo​philes of the quinazolinone.
Conclusions
In this paper, we report that di​meth​yl​formamide di(primary-alk​oxy)​acetals 1a-c and dimethyl​acet​amide di​meth​yl​acetal 1d can elim​inate one alk​oxide therm​ally to generate cat​ion​ic inter​med​iates 34a-d that can act as elec​tro​philes at two sites. First​ly, the pre​dic​t​able cyclo​con​densation of anthr​anilamides 7-12 with 1 gen​er​ates quinazolin-4-ones through attack on the central carbon, which is sp2 in 34. This cyclocondensation also takes place read​ily with 7 and the electrophilic sp2-carbon of the corresponding cat​ion​ic inter​med​iates 34e-g, der​ived from more sterically bulky di​iso​propoxy, di-t-butoxy and di​neo​pent​yl acetals 1e-g. Sec​ondly, nucleo​philic attack also takes place at the alkoxy sp3 carbon of un​hin​d​ered primary inter​mediates 34a-d, forming 3-alkyl​quin​az​olin-4-ones 26-32 from the N-H quin​az​olin-4-ones 19-25. This sec​ond reaction of 1 as electro​philic alkyl​ating agents is unprec​ed​ented. Incr​easing the steric bulk of the O-alkyl substituent in the cationic inter​mediates 34e,g mitigates this second electrophile but reveals a third site, the N-methyl. Reaction of N-H quin​az​ol​in-4-one 19a with these electrophiles gives the N3-Me quin​azolin-4-one 26a as major products. These reactions provide a useful one-pot route to N3-(prim​ary-alkyl)​quin​az​ol​in-4-ones and point to new applic​ations of these orthoamides as electro​philic alkyl​ating agents in hetero​cyclic and other chemistry. 
Experimental
NMR spectra were recorded on Bruker Avance III 400 and 500 spec​tro​meters of solut​ions in hexadeuteriodimethylsulfoxide, except as otherwise noted; coup​ling constants are given in Hz. Mass spectra were obtained using Bruker microTOF spectro​​meters in electro​spray positive ion mode. IR spectra were obtained as KBr discs. The stationary phase for chrom​ato​graphy was silica gel. Melting points were deter​mined using a Reichert-Jung Thermo Galen instrument and are uncorr​ected. Reactions were per​formed at ambient temperature, unless stated otherwise. The sol​vents were evaporated under reduced pressure. Solutions in org​anic solvents were dried with sodium sulfate. The brine was saturated.
2-Amino-3-nitrobenzamide (8)
2-Amino-3-nitrobenzoic acid 2 (5.1 g, 28 mmol) was suspended in tetrahydrofuran (50 mL). Thionyl choride (5.0 g, 42 mmol) and di​methylformamide (100 L) were added and the mixture was stirred for 16 h. This solution was added dropwise to aq. ammonia (35%, 200 mL). Filtration and drying gave 8 (4.02 g, 79%) as an orange solid: mp 240-242C (lit.18 mp 234-235C); max 3458, 3431, 3297, 3207, 1686, 1630, 1596, 1544, 1320 cm-1; H 6.66 (1 H, t, J 6.8, 5-H), 7.59 (1 H, br s, CONH), 7.94 (1 H, dd, J 6.0, 1.2, 6-H), 8.14 (1 H, br s, CONH), 8.17 (1 H, dd, J 6.8, 1.2, 4-H), 8.64 (2 H, br s, Ar-NH2); C (HSQC / HMBC)  113.67 (5-C), 118.82 (3-C), 129.40 (6-C), 132.13 (1-C), 136.41 (4-C), 146.03 (2-C), 169.93 (C=O). 
2-Amino-3-methylbenzamide (9)
2-Amino-3-methylbenzoic acid 3 (2.93 g, 19.8 mmol) in dry di​meth​ylformamide (78 mL) was treated with 1,1’-carbonyl​di​imid​azole (3.14 g, 19.4 mmol) at 70°C under argon for 1 h, after which aq. ammonia (35%, 49 mL) was added drop​wise. The mix​ture was stirred for 16 h. The mixture was allow​ed to cool to 20C and dil​uted with ethyl acetate (100 mL). Washing (water (twice), brine (twice)), drying and evaporation gave 9 (2.14 g, 98%) as a white solid: mp 150-152C (lit.19 mp 147-149C); max 3468, 3392, 3353, 3190, 1641, 1608, 1569 cm-1; H 2.05 (3 H, s, Me), 6.35 (2 H, br s, Ar-NH2), 6.41 (1 H, br t, J 7.6, 5-H), 6.89 (1 H, br s, CONH), 7.04 (1 H, d, J 6.8, 6-H), 7.34 (1 H, dd, J 8.0, 0.8, 4-H), 7.67 (1 H, br s, CONH); C (HSQC / HMBC) 17.56 (Me), 113.59 (1-C), 114.17 (5-C), 122.99 (3-C), 126.61 (6-C), 132.67 (4-C), 148.21 (2-C), 171.73 (C=O).
2-Amino-3-methoxybenzamide (10)
2-Amino-3-methoxybenzoic acid 4 was treated with 1,1’-car​bon​yl​diimidazole as for the syn​th​esis of 9, to give 10 (80%) as a white solid: mp 139-141C (lit.20 mp 140-141C); max 3474, 3367, 3304, 3150, 1670, 1617, 1548 cm-1; H 3.77 (3 H, s, Me), 6.23 (2 H, br s, Ar-NH2), 6.44 (1 H, t, J 8.0, 5-H), 6.85 (1 H, dd, J 7.6, 0.8, 6-H), 7.03 (1 H, br s, CONH), 7.16 (1 H, dd, J = 8.0, 1.2, 4-H), 7.67 (1 H, br s, CONH); C (HSQC / HMBC) 55.53 (Me), 111.98 (6-C), 113.38 (3-C), 113.64 (5-C), 120.42 (4-C), 140.19 (1-C), 146.88 (2-C), 171.19 (C=O). 
2-Amino-3-chlorobenzamide (11)
2-Amino-3-chlorobenzoic acid 5 was treated with 1,1’-carb​on​yl​diimidazole, as for the syn​thesis of 9, to give 11 (97%) as a white solid: mp 155-157C (lit.21 mp 161-162C); max 3436, 3398,  3277, 3222, 1640, 1607, 1573, 1542 cm-1; H 6.51 (1 H, t, J 8.0, 5-H), 6.66 (2 H, br s, Ar-NH2), 7.26 (1 H, br s, CONH), 7.34 (1 H, dd, J 7.6, 1.2, 6-H), 7.53 (1 H, dd, J 8.0, 1.6, 4-H), 7.86 (1 H, br s, CONH); C (HSQC / HMBC) 114.89 (1-C), 115.84 (5-C), 119.03 (3-C), 127.74 (6-C), 131.83 (4-C), 145.62 (2-C), 170.45 (C=O).
Methyl 2-amino-3-aminocarbonyl​benzoate (12)
Methyl 2-amino-3-carboxybenzoate 6 was treated with 1,1’-car​bon​yl​di​imid​azole, as for the syn​thesis of 9, to give 12 (84%) as a white solid: mp 75-77C; max 3455, 3437, 3285, 3200, 1682 (br), 1575 cm-1; H 3.78 (3 H, s, Me), 6.52 (1 H, t, J 7.8, 5-H), 6.99 (0.5 H, br s, CONH), 7.28 (1 H, br s, CONH), 7.61 (0.5 H, br s, CONH), 7.77 (1 H, dd, J 7.7, 1.6, 6-H), 7.87 (1 H, dd, J 7.9, 1.6, 4-H), 7.99 (2 H, br s, Ar-NH2); C (HSQC / HMBC) 51.63 (Me), 110.51 (1-C), 113.21 (5-C), 116.17 (3-C), 134.56 (6-C), 134.64 (4-C), 151.59 (2-C), 167.54 (CO2Me), 170.72 (CONH2); m/z 217.0619 (M + Na) (C9H10N2NaO3 requires 217.0589).
Quinazolin-4-one (19a)
2-Aminobenzamide 7 (500 mg, 3.7 mmol) in di​meth​yl​form​amide (18 mL) was treated with 1a (1.27 g, 10.6 mmol) at 150°C for 1.5 h. Cooling, evaporation and chromatography (ethyl acet​ate / dichloromethane 1:4 → 2:3) gave 19a (410 mg, 75%) as a white solid: mp 225-227°C (lit.22 mp 221-222C); H 7.58 (1 H, ddd, J 8.1, 7.3, 1.1, 6-H), 7.72 (1 H, ddd, J 8.1, 1.2, 0.5, 8-H), 7.87 (1 H, ddd, J 8.2, 7.2, 1.6, 7-H), 8.15 (1 H, s, 2-H), 8.18 (1 H, ddd, J 8.0, 1.6, 0.4, 5-H), 12.3 (1 H, br, 3-H); C (HSQC / HMBC) 122.64 (4a-C), 125.80 (5-C), 126.70 (6-C), 127.21 (8-C), 134.27 (7-C), 145.33 (8a-C), 148.77 (2-C), 160.68 (4-C).
3-Methylquinazolin-4-one (26a)
Amide 7 (500 mg, 3.7 mmol) in dimethylformamide (16 mL) was treated with 1a (1.3 g, 11 mmol) at 150°C for 16 h. Cooling, evap​oration and chromatography (ethyl acetate / petroleum ether, 2:3 → ethyl acetate) gave 26a (560 mg, 95%) as a white solid: mp 98-100C (lit.11 mp 105C); max 1670, 1614 cm-1; H 3.55 (3 H, s, Me), 7.60 (1 H, ddd, J 8.1, 7.2, 1.2, 6-H), 7.73 (1 H, ddd, J 8.2, 1.2, 0.5, 8-H), 7.87 (1 H, ddd, J 8.2, 7.1, 1.6, 7-H), 8.43 (1 H, ddd, J 8.0, 1.5, 0.5, 5-H), 8.34 (1 H, s, 2-H); C (HSQC / HMBC) 33.49 (Me), 121.43 (4a-C), 125.82 (5-C), 126.91 (6-C), 127.12 (8-C), 134.09 (7-C), 148.10 (8a-C), 148.41 (2-C), 160.64 (4-C). 
3-Ethylquinazolin-4-one (26b)
Amide 7 (500 mg, 3.7 mmol) in dimethylformamide (16 mL) was treated with 1b (1.3 g, 11 mmol) at 150°C for 16 h. Cooling, evap​oration and chrom​ato​graphy (ethyl acetate / petroleum ether 1:4 → 1:1) gave 26b (330 mg, 52%) as a white solid: mp 110-112C (lit.12 mp 99-101C); max 1676, 1613 cm-1; H 1.27 (3 H, t, J 7.5, Me), 3.99 (2 H, q, J 7.5, CH2), 7.52 (1 H, t, J 8.0, 6-H), 7.66 (1 H, d, J 8.0, 8-H), 7.80 (1 H, br t, J 7.5, 7-H), 8.15 (1H, br d, J 8.0, 5-H), 8.41 (1 H, s, 2-H); C (HSQC / HMBC) 14.49 (Me), 41.19 (CH2), 121.57 (4a-C), 125.94 (5-C), 126.92 (6-C), 127.13 (8-C), 134.15 (7-C), 147.84 (8a-C), 147.99 (2-C), 159.97 (4-C).
3-Phenylmethylquinazolin-4-one (26c)
Amide 7 (200 mg, 1.5 mmol) was stirred at 150C with 1c (2.00 g, 7.3 mmol) in dimethylformamide (8.0 mL) for 24 h. Evap​or​at​ion and chromatography (ethyl acetate / petroleum ether 1:4 → 7:1) gave 26c (286 mg, 82%) as a white solid: mp 117-119C; (lit.16 mp 118-120C); max 1674, 1604 cm-1; H 5.20 (2 H, s, CH2), 7.29-7.38 (5 H, m, Ph-H5); 7.55 (ddd, J 8.0, 7.0, 1.1, 6-H), 7.69 (1 H, brd, J 8.0, 8-H), 7.84 (1 H, ddd, J 8.1, 7.0, 1.5, 7-H), 8.15 (1 H, dd, J 8.0, 1.2, 5-H), 8.58 (1 H, s, 2-H); C (HSQC / HMBC) 48.84 (CH2), 121.64 (4a-C), 126.11 (8-C), 127.19 (6-C), 127.26 (5-C), 127.64 and 128.64 (Ph 2,3,5,6-C4), 127.67 (Ph 4-C), 134.43 (7-C), 136.85 (Ph 1-C), 147.91 (8a-C), 148.01 (2-C), 160.09 (4-C); m/z 495.1777 (2 M + Na) (C30H24N4NaO2 requires 495.1806); 259.0848 (M + Na) (C15H12N2NaO requires 259.0847), 237.1043 (M + H) (C15H13N2O requires 237.1029).
2,3-Dimethylquinazolin-4-one (26d)
Amide 7 (200 mg, 1.47 mmol) was stirred at 150°C with 1d (783 mg, 5.9 mmol) in dimethylformamide (8.0 mL) for 2 d. Evap​oration and chromatography (CH2Cl2 → CH2Cl2 / EtOAc 4:1) gave 26d (30 mg, 12%) as a white solid: mp 110-112C (lit.12 mp 108-109C); max 1671, 1600 cm-1; H 2.57 (3 H, s, 2-Me), 3.53 (3 H, s, 3-Me), 7.46 (1 H, ddd, J 8.0, 6.8, 0.8, 6-H), 7.56 (1 H, brd, J 8.0 Hz, 8-H), 7.77 (1 H, ddd, J 8.4, 7.2, 1.6 Hz, 7-H), 8.09 (1 H, dd, J 8.0, 1.2 Hz, 5-H); C (HSQC / HMBC) 23.15 (2-Me), 30.52 (3-Me), 119.70 (4a-C), 126.05 (6-C), 126.12 (5-C), 126.41 (8-C), 134.09 (7-C), 155.60 (2-C), 161.27 (4-C).
3-Methyl-8-nitroquinazolin-4-one (27a)
Amide 8 was treated with 1a, as for the synthesis of 19a except that the chrom​ato​g​raphic eluant was ethyl acetate / petroleum ether (1:4 → 1:1), to give 27a (93%) as a pale yellow solid: mp 165-167C (lit.23 mp 157C); max 1697, 1614, 1604, 1526, 1366 cm-1; H 3.49 (3 H, s, Me), 7.63 (1 H, t, J 8.6, 6-H), 8.26 (1 H, dd, J 8.0, 1.6, 7-H), 8.34 (1 H, dd, J 8.0, 1.6, 5-H), 8.47 (1 H, s, 2-H); C (HSQC / HMBC) 33.86 (Me), 122.83 (4a-C), 126.56 (5-C), 127.58 (6-C), 129.64 (7-C), 139.85 (8-C), 146.45 (8a-C), 150.97 (2-C), 159.31 (4-C).
3-Ethyl-8-nitroquinazolin-4-one (27b)
Amide 8 was treated with 1b, as for the synthesis of 26b, to give 27b (89%) as a pale yellow solid: mp 143-145C (lit.24 mp 143-144C); max 1683, 1526, 1379 cm-1; H 1.27 (3 H, t, J 7.2, Me), 3.98 (2 H, q, J 7.2, CH2), 7.64 (1 H, t, J 7.6, 6-H), 8.26 (1 H, dd, J8.0, 1.6, 7-H), 8.35 (1 H, dd, J 8.0, 1.2, 5-H), 8.53 (1 H, s, 2-H); C (HSQC / HMBC) 14.20 (Me), 41.74 (CH2), 123.00 (4a-C), 126.61 (5-C), 127.63 (6-C), 129.76 (7-C), 139.74 (8-C), 146.47 (8a-C), 150.43 (2-C), 158.69 (4-C); m/z 242.0535 (M + Na) (C10H9N3NaO3 requires 242.0542), 220.0719 (M + H) (C10H10N3O3 requires 220.0722).
8-Nitro-3-(phenylmethyl)quinazolin-4-one (27c)
Amide 8 (200 mg, 1.1 mmol) was stirred at 150C with 1c (1.2 g, 4.4 mmol) in dimethylformamide (4.0 mL) for 5 d. Evap​or​ation and chromato​graphy (ethyl acetate / petroleum ether 1:1) gave 27c (190 mg, 61%) as pale yellow crystals: mp 189-191C; max 1691, 1602, 1527, 1356 cm-1; H ((CD3)2SO) 5.27 (2 H, s, CH2), 7.36 (5 H, m, Ph-H5), 7.76 (1 H, t, J 8.0, 6-H), 8.38 (1 H, dd, J 8.0, 1.2, 7-H), 8.44 (1 H, dd, J 8.0, 1.6, 5-H), 8.78 (1 H, s, 2-H); H (CDCl3) 5.21 (2 H, s, CH2), 7.35 (5 H, m, Ph-H5), 7.58 (1 H, t, J 8.0, 6-H), 8.09 (1 H, dd, J 8.0, 1.5, 7-H), 8.23 (1 H, s, 2-H), 8.53 (1 H, dd, J 8.0, 1.5, 5-H);C (HSQC / HMBC) (CDCl3) 50.07 (CH2), 123.74 (4a-C), 126.54 (6-C), 128.24 and 129.18 (Ph 2,3,5,6-C4), 128.52 (7-C), 128.71 (Ph 4-C), 131.08 (5-C), 134.71 (Ph 1-C), 140.46 (8a-C), 146.63 (8-C), 148.60 (2-C), 159.42 (4-C); m/z 585.1460 (2 M + Na) (C30H22N6NaO6 requires 585.1493), 304.0686 (M + Na) (C15H11N3NaO3 requires 304.0693), 282.0879 (M + H) (C15H12N3O3 requires 282.0873).
2,3-Dimethyl-8-nitroquinazolin-4-one (27d)
2-Amino-3-nitrobenzamide 8 (200 mg, 1.1 mmol) was stirred at 150C with 1d (441 mg, 3.3 mmol) in dimethylformamide (4.0 mL) for 5 d. Evaporation and chromatography (dichloromethane) gave 27d (180 mg, 75%) as a pale yellow solid: mp 178-179C (lit.25 mp 175C); H ((CD3)2SO) 2.64 (3 H, s, 2-Me), 3.60 (3 H, s, 3-Me), 7.66 (1 H, t, J 8.0, 6-H), 8.30 (1 H, dd, J 7.6, 1.6, 7-H), 8.39 (1 H, dd, J 8.0, 1.6, 5-H); H (CDCl3) 2.65 (3 H, s, 2-Me), 3.63 (3 H, s, 3-Me), 7.48 (1 H, t, J 8.0, 6-H), 8.00 (1 H, dd, J 7.8, 1.4, 7-H), 8.43 (1 H, dd, J 8.0, 1.5, 5-H); H (HSQC / HMBC) (CDCl3) 24.06 (2-Me), 31.30 (3-Me), 121.85 (4a-C), 125.31 (6-C), 128.04 (7-C), 130.82 (5-C), 139.73 (8a-C), 146.29 (8-C), 157.42 (2-C), 160.72 (4-C); m/z 242.0521 (M + Na) (C10H9N3NaO3 requires 242.0542), 220.0748 (M + H) (C10H10N3O3 requires 220.0722).
3,8-Dimethylquinazolin-4-one (28a)
Amide 9 was treated with 1a, as for the synthesis of 26a except that the chrom​ato​g​raphic eluant was ethyl acetate / petroleum ether (1:4 → 3:7), to give 28a (0.41 g, 71%) as a white solid: mp 151-153C; max 1667, 1612, 1574 cm-1; H 2.52 (3 H, s, 8-Me), 3.49 (3 H, s, 3-Me), 7.39 (1 H, t, J 7.5, 6-H), 7.64 (1 H, ddq, J 8.0, 2.5, 0.5, 7-H), 7.97 (1 H, brd, J 8.0, 5-H), 8.35 (1 H, s, 2-H); C (HSQC / HMBC) 17.02 (8-Me), 33.43 (3-Me), 121.35 (4a-C), 123.48 (5-C), 126.38 (6-C), 134.38 (7-C), 135.26 (8-C), 146.57 (8a-C), 147.37 (2-C), 160.85 (4-C); m/z 371.1450 (2 M + Na) (C20H20N4NaO2 requires 371.1478), 197.0680 (M + Na) (C10H10N2NaO requires 197.0691), 175.0874 (M + H) (C10H11N2O requires 175.0871).
3-Ethyl-8-methylquinazolin-4-one (28b)
Amide 9 was treated with 1b, as for the synthesis of 26b except that the chromato​g​raphic eluant was ethyl acetate / petroleum ether (1:4), to give 28b (45%) as a white solid: mp 67-69C; max 1678, 1607, 1574, 1456 cm-1; H 1.25 (3 H, t, J 7.2, CH2CH3), 2.50 (3 H, s, 8-Me), 3.96 (2 H, q, J 7.2, CH2), 7.36 (1 H, t, J 7.6, 6-H), 7.63 (1 H, br d, J 7.2, 7-H), 7.96 (1 H, br d, J 8.0, 5-H), 8.39 (1 H, s, 2-H); C (HSQC / HMBC) 14.47 (CH2CH3), 16.97 (8-Me), 41.10 (CH2), 121.53 (4a-C), 123.61 (5-C), 126.40 (6-C), 134.43 (7-C), 135.28 (8-C), 146.47 (8a-C), 146.80 (2-C), 160.20 (4-C); m/z 211.0846 (M + Na) (C11H12N2NaO requires 211.0847), 189.1033 (M + H) (C11H13N2O requires 189.1028).
8-Methyl-3-phenylmethylquinazolin-4-one (28c)
Amide 9 was treated with 1c, as for the synthesis of 26c except that the chromatographic eluant was ethyl acetate / petroleum ether (1:9 → 7:1), to give 28c (83%) as pale buff solid: mp 143-145C; max 1673, 1603 cm-1; H 2.54 (3 H, s, 8-Me), 5.20 (2 H, s, CH2), 7.28-7.36 (5 H, m, Ph-H5), 7.43 (1 H, t, J 8.0, 6-H), 7.69 (1 H, dd, J 7.6, 1.6, 7-H), 7.99 (1 H, dd, J 8.0, 0.8, 5-H), 8.59 (1 H, s, 2-H); C (HSQC / HMBC) 17.03 (Me), 48.79 (CH2), 121.58 (4a-C), 123.76 (5-C) 126.69 (6-C), 127.61 and 128.62 (Ph 2,3,5,6-C4), 127.64 (Ph 4-C), 134.74 (7-C), 135.47 (8-C), 136.86 (Ph 1-C), 146.37 (8a-C), 147.02 (2-C), 160.31 (4-C); m/z 523.2085 (2 M + Na) (C32H28N4Na1O2 requires 523.2104), 273.0985 (M + Na) (C16H14N2Na1O1 requires 273.0998), 251.1186 (M + H) (C16H15N2O1 requires 251.1179).
2,3,8-Trimethylquinazolin-4-one (28d)
Amide 9 (50 mg, 0.33 mmol) was stirred at 150C with 1d (133 mg, 1.0 mmol) in dimethylformamide (1.5 mL) for 90 h. Evap​or​at​ion and chromatography (ethyl acetate / petroleum ether 1:4) gave 27d (18.9 mg, 38%) as a white solid: mp 104-108C (lit.26 mp 107C); H ((CD3)2SO) 2.14 (3 H, s, 8-Me), 2.65 (3 H, s, 2-Me), 3.59 (3 H, s, 3-Me), 7.40 (1 H, t, J 8.0, 6-H), 7.68 (1 H, ddq, J 8.0, 1.2, 0.5, 7-H), 8.00 (1 H, dd, J 8.0, 1.2, 5-H); H (CDCl3) 2.56 (3 H, s, 8-Me), 2.59 (3 H, s, 2-Me), 3.59 (3 H, s, 3-Me), 7.28 (1 H, t, J 7.5, 6-H), 7.72 (1 H, brd, J 7.5, 7-H), 8.07 (1 H, brd, J 7.5, 5-H); C (HSQC / HMBC) (CDCl3) 17.13 (8-Me), 23.76 (2-Me), 30.90 (3-Me), 120.07 (4a-C), 124.31 (5-C), 125.75 (7-C), 134.53 (7-C), 135.09 (8-C), 145.84 (8a-C), 152.90 (2-C), 162.65 (4-C). m/z 399.1828 (2 M + Na) (C22H24N4NaO2 requires 399.1782), 211 (M + Na), 189 (M + H).
8-Methoxy-3-methylquinazolin-4-one (29a)
Amide 10 was treated with 1a, as for the synthesis of 26a except that the chrom​ato​g​raphic eluant was ethyl acetate, to give 29a (64%) as a white solid: mp 177-179C (lit.9 mp 172C); max 1677, 1602, 1548 cm-1; H 3.47 (3 H, s, 3-Me), 3.88 (3 H, s, OMe), 7.31 (1 H, dd, J 8.0, 1.2, 7-H), 7.41 (1 H, t, J 8.0, 6-H), 7.66 (1 H, dd, J 8.0, 1.2, 5-H), 8.23 (1 H, s, 2-H); C (HSQC / HMBC) 33.42 (3-Me), 55.96 (OMe), 114.63 (5-C), 116.79 (7-C), 122.52 (4a-C), 127.23 (6-C), 138.70 (8a-C), 146.97 (2-C), 154.48 (8-C), 160.50 (4-C). 
3-Ethyl-8-methoxyquinazolin-4-one (29b)
Amide 10 was treated with 1b, as for the synthesis of 26b except that the chromato​g​raphic eluant was ethyl acetate / petroleum ether (1:4) → EtOAc, to give 29b (43%) as a white solid: mp 115-116C (lit.9 mp 108C); max 1680, 1604, 1570 cm-1; H 1.24 (3 H, t, J 6.8 Hz, CH2CH3), 3.89 (3 H, s, OMe), 3.96 (2 H, q, J 6.8, CH2), 7.32 (1 H, dd, J 8.0, 1.2, 7-H), 7.42 (1 H, t, J 8.0, 6-H), 7.67 (1 H, dd, J 8.0, 1.2, 5-H), 8.32 (1 H, s, 2-H); C (HSQC / HMBC) 14.44 (CH2CH3), 41.16 (CH2), 55.99 (OMe), 114.73 (5-C), 116.91 (7-C), 122.68 (4a-C), 127.26 (6-C), 138.59 (8a-C), 146.39 (2-C), 154.49 (8-C), 159.85 (4-C).
8-Methoxy-3-phenylmethylquinazolin-4-one (29c)
Amide 10 was treated with 1d, as for the synthesis of 26c except that the chromato​g​raphic eluant was ethyl acetate / petroleum ether (2:3 → 7:1), to give 29c (72%) as a white solid: mp 121-123C (lit.9 mp 118C); max 1688, 1605, 1570, 1483 cm-1; H (COSY) 3.90 (3 H, s, OMe), 5.20 (2 H, s, CH2), 7.28-7.35 (5 H, m, Ph-H5), 7.38 (1 H, slightly br dd, J 8.0, 1.3, 7-H), 7.47 (1 H, t, J 8.0, 6-H), 7.69 (1 H, dd, J 8.0, 1.3 Hz, 5-H), 8.51 (1 H, s, 2-H); C (HSQC / HMBC) 48.82 (CH2), 56.00 (OMe), 114.96 (7-C), 117.01 (5-C), 122.73 (4a-C), 127.60 (Ph 2,4,6-C3), 127.65 (6-C), 128.64 (Ph 3,5-H2), 136.85 (Ph 1-C), 138.42 (8a-C), 146.61 (2-C), 154.55 (8-C), 160.00 (4-C); m/z 555 (2 M + Na), 289.0984 (M + Na) (C16H14N2NaO2 requires 289.0953), 267 (M + H).
2,3-Dimethyl-8-methoxyquinazolin-4-one (29d)
Amide 10 (95 mg, 0.57 mmol) was stirred at 150C with 1d (230 mg, 1.7 mmol) in dimethylformamide (2.3 mL) for 24 h. Evap​or​at​ion and chromatography (ethyl acetate / methanol 19:1) gave 29d (28 mg, 24%) as a white solid: mp 133C (lit.27 mp 133-136C); H 2.63 (3 H, s, 2-Me), 3.59 (3 H, s, 3-Me), 3.95 (3 H, s, OMe), 7.36 (1 H, dd, J 8.0, 1.2, 7-H), 7.44 (1 H, t, J 8.0, 6-H), 7.70 (1 H, dd, J 8.0, 1.2, 5-H); C (HSQC / HMBC) 23.19 (2-Me), 30.60 (3-Me), 55.74 (O-Me), 114.35 (7-C), 117.07 (5-C), 120.73 (8-C), 126.27 (6-C), 137.68 (8a-C), 154.21 (4a-C), 161.15 (4-C); m/z 205.0976 (M + H) (C11H13N2O2 requires 205.0977).
8-Chloro-3-methylquinazolin-4-one (30a)
Amide 11 was treated with 1a, as for the synthesis of 26a, to give 30a (63%) as a white solid: mp 160-162C (lit.14 mp 158-159C); max 1672, 1609 cm-1; H 3.49 (3 H, s, Me), 7.46 (1 H, t, J 7.8, 6-H), 7.92 (1 H, dd, J 7.8, 1.3, 5-H), 8.07 (1 H, dd, J 8.0, 1.2, 7-H), 8.45 (1 H, s, 2-H); C (HSQC / HMBC) 33.69 (Me), 123.13 (4a-C), 125.03 (5-C), 127.25 (6-C), 130.66 (7-C), 134.17 (8-C), 144.58 (8a-C), 149.27 (2-C), 160.12 (4-C). 
8-Chloro-3-ethylquinazolin-4-one (30b)
Amide 11 was treated with 1b, as for the synthesis of 26b except that the chromato​g​raphic eluant was ethyl acetate / petroleum ether (1:4 → 3:7), to give 30b (58%) as a white solid: mp 127-128C (lit.24 mp 123-123.5C); max 1679, 1607 cm-1; H 1.26 (3 H, t, J 7.2, CH2CH3), 3.98 (2 H, q, J 7.2, CH2), 7.47 (1 H, t, J 8.0, 6-H), 7.93 (1 H, dd, J 7.6, 1.2, 7-H), 8.08 (1 H, dd, J 8.0, 1.6, 5-H), 8.49 (1 H, s, 2-H); C (HSQC / HMBC) 14.31 (CH2CH3), 41.49 (CH2), 123.29 (4a-C), 125.16 (5-C), 127.29 (6-C), 130.69 (7-C), 134.23 (8-C), 144.48 (8a-C), 148.72 (2-C), 159.48 (4-C).
Methyl 3-methyl-4-oxoquinazoline-8-carboxylate (31a)
Amide 12 was treated with 1a, as for the synthesis of 27a, to give 31a (66%) as a white solid: mp 180-182C; max 1740, 1681, 1610 cm-1; H 3.48 (3 H, s, 3-Me), 3.86 (3 H, s, OMe), 7.54 (1 H, t, J 7.6, 6-H), 7.95 (1 H, dd, J 7.6, 1.6, 7-H), 8.26 (1 H, dd, J 8.0, 1.6, 5-H), 8.38 (1 H, s, 2-H); C (HSQC / HMBC) 33.57 (3-Me), 52.33 (OMe), 121.90 (4a-C), 126.36 (5-C), 128.54 (6-C), 130.65 (7-C), 133.32 (8-C), 145.35 (8a-C), 149.14 (2-C), 160.14 (4-C); MS m/z 219.0777 (M + H) (C11H11N2O3 requires 219.0769).
Ethyl 3-ethyl-4-oxoquinazoline-8-carboxylate (32b)
Amide 12 was treated with 1b, as for the synthesis of 7a except that the chromatographic eluant was ethyl acetate / petroleum ether (3:7 → 1:1), to give 32b (40%) as a white solid: mp 113-115C; max 1727, 1672, 1606 cm-1; H 1.26-1.32 (6 H, m, 2  Me), 3.97 (2 H, q, J 7.2, 3-CH2), 4.30 (2 H, q, J 7.2, OCH2), 7.55 (1 H, t, J 7.6, 6-H), 7.94 (1 H, dd, J 7.6, 1.6, 7-H), 8.26 (1 H, dd, J 8.0, 1.6, 5-H), 8.43 (1 H, s, 2-H); C (HSQC / HMBC) 14.09 (3-CH2CH3), 14.34 (OCH2CH3), 41.34 (3-CH2), 61.05 (OCH2), 122.03 (4a-C), 126.39 (5-C), 128.47 (6-C), 131.04 (7-C), 133.12 (8-C), 145.19 (8a-C), 148.53 (2-C), 159.51 (4-C), 166.68 (CO2); m/z 269.0939 (M + Na) (C13H14N2NaO3 requires 269.0902), 247.1132 (M + H) (C13H15N2O3 requires 247.1083).
N’-(2-Amino-3-nitrobenzoyl)-N,N-dimethylformamidine (33)
Amide 8 (200 mg, 1.1 mmol) was heated under reflux with 1a (157 mg, 1.3 mmol) in tetrahydrofuran (4.0 mL) for 16 h. The evap​oration residue, in ethyl acetate, was washed with water. The com​bined aq. washings were then extracted thrice with ethyl acet​ate. The combined organic extracts were dried. Evaporation gave an orange solid (221 mg). 1H NMR showed that the solid com​p​rised 20a (19% yield), 27a (21% yield) and 33 (52% yield). Spec​t​ro​scopic data for 33: H (COSY / NOESY) 3.13 (3 H, d, J 0.5, Me trans to form​am​id​ine-H), 3.23 (3 H, s, Me cis to form​am​id​ine-H), 6.67 (1 H, br t, J 8.0, 5-H), 8.22 (1 H, dd, J 8.5, 4-H), 8.61 (1 H, br s, N=CH), 8.62 (1 H, m, 6-H); C (HSQC / HMBC) 35.38 (Me trans to formamidine-H), 41.19 (Me cis to form​am​id​ine-H), 113.53 (5-C), 121.14 (1-C), 130.54 (4-C), 132.26 (3-C), 140.39 (6-C), 147.31 (2-C), 160.35 (N=CH), 176.82 (C=O).
Reaction of 7 with 1e
2-Aminobenzamide 7 (200 mg, 1.47 mmol) was stirred at 150C with 1e (1.29 g, 7.3 mmol) in dimethylformamide (8.0 mL) for 24 h. Further 1e (773 mg, 4.4 mmol) was added and the mix​ture was stirred at 150C for 24 h. Evaporation gave a colourless oil, which was shown by 1H NMR to comprise 19a, 26a, 3-(prop-2-yl)​quin​azolin-4-one 26e and 4-(prop-2-yl​oxy)​quinazoline 47e (1.4:2.3:1.4:1.0): H (19a) 7.53 (1 H, brt, J 8, 6-H), 7.67 (1 H, brd, J 8, 8-H), 7.81 (1 H, brt, J 8, 7-H), 8.13 (1 H, brd, J 7.5, 5-H), 8.09 (1 H, s, 2-H), 12.5 (1 H, br, 3-H); C (HSQC / HMBC) (19a) 121.58 (4a-C), 123.24 (5-C), 126.8 (6-C), 127 (8-C), 134.32 (7-C), 148 (8a-C), 147.42 (2-C), 160.65 (4-C); H (26a) 3.50 (3 H, s, 3-Me), 7.53 (1 H, brt, J 8, 6-H), 7.67 (1 H, brd, J 8, 8-H), 7.81 (1 H, brt, J 8, 7-H), 8.15 (1 H, dd, J 7.0, 1.0, 5-H), 8.37 (1 H, s, 2-H); C (HSQC / HMBC) (26a) 33.85 (3-Me), 121.45 (4a-C), 125.84 (5-C), 126.8 (6-C), 127 (8-C), 134.21 (7-C), 148.13 (8a-C), 148.44 (2-C), 160.65 (4-C); H (26e) 1.436 (6 H, d, J 7.0, CHMe2), 5.00 (1 H, septet, J 7.0, CHMe2), 7.53 (1 H, brt, J 8, 6-H), 7.67 (1 H, brd, J 8, 8-H), 7.81 (1 H, brt, J 8, 7-H), 8.15 (1 H, dd, J 7.0, 1.0, 5-H), 8.47 (1 H, s, 2-H); C (HSQC / HMBC) (26e) 21.17 (CHMe2), 45.09 (CHMe2), 121.40 (4a-C), 125.83 (5-C), 126.8 (6-C), 127 (8-C), 134.12 (7-C), 148 (8a-C), 145.35 (2-C), 159.7 (4-C); H (47e) 1.436 (6 H, d, J 6.4, CHMe2), 5.58 (1 H, septet, J 6.0, CHMe2), 7.52 (1 H, brt, J 7.5, 6-H), 7.90 (1 H, brd, J 8, 8-H), 7.93 (1 H, brt, J 8, 7-H), 8.15 (1 H, dd, J 7.0, 1.0, 5-H), 8.78 (1 H, s, 2-H); C (HSQC / HMBC) (47e) 21.53 (CHMe2), 70.01 (CHMe2), 116.1 (4a-C), 126 (5-C), 126.8 (6-C), 127.4 (8-C), 134.00 (7-C), 150.54 (8a-C), 153.34 (2-C), 165.5 (4-C); m/z 189.1018 (26e/47e + H) (C11H13N2O requires 189.1028), 147.0546 (19a + H) (C8H7N2O requires 147.0558).
Reaction of 8 with 1e; synthesis of 8-nitro-3-(prop-2-yl)​quin​az​olin-4-one (27e)
2-Amino-3-nitrobenzamide 8 (25 mg, 0.14 mmol) was stirred at 150C with 1e (115 mg, 0.66 mmol) in DMF (0.55 mL) for 4 d. Evap​oration and chromatography (ethyl acetate / pet​roleum ether 1:4) gave 27e (0.7 mg, 3%) as a pale yellow solid: mp 165-167C; H 1.50 (6 H, d, J 6.8, 2  Me), 5.03 (1 H, septet, J 6.8, CHMe​2), 7.74 (1 H, t, J 8.0, 6-H), 8.36 (1 H, dd, J 8.0, 1.6, 7-H), 8.45 (1 H, dd, J 8.0, 1.6, 5-H), 8.67 (1 H, s, 2-H); m/z 489.1461 (2 M + Na) (C22H22N6NaO6 requires 489.1499), 256.0685 (M + Na) (C11H11N3NaO3 requires 256.0693), 234.0890 (M + H) (C11H12N3O3 requires 234.0873).
Reaction of 9 with 1e
2-Amino-3-methylbenzamide 9 was treated with 1e, as for the reaction of 7 with 1e, to give a colourless oil, which was shown by 1H NMR to comprise 21a, 28a, 8-methyl-3-(prop-2-yl)​quin​az​ol​in-4-one 28e and 8-methyl-1-(prop-2-yloxy)quinazoline 49e (2.9:2.2:1.3:1.0): H (21a) 2.5 (3 H, s, 8-Me), 7.38 (1 H, m, 6-H), 7.64 (1 H, brd, J 8, 7-H), 7.92 (1 H, m, 5-H), 8.11 (1 H, s, 2-H), 12.25 (1 H, br, 3-H); C (HSQC / HMBC) (21a) 17.23 (8-Me), 122.56 (4a-C), 123.5 (5-C), 126.14 (6-C), 134.62 (7-C), 146.58 (8a-C), 147 (2-C), 135.2 (8-C), 161.00 (4-C); H (28a) 2.5 (3 H, s, 8-Me), 3.48 (3 H, s, 3-Me), 7.38 (1 H, m, 6-H), 7.64 (1 H, brd, J 8, 7-H), 7.92 (1 H, m, 5-H), 8.35 (1 H, s, 2-H); C (HSQC / HMBC) (28a) 33.44 (3-Me), 17.03 (8-Me), 121.35 (4a-C), 123.5 (5-C), 126.37 (6-C), 134.36 (7-C), 135.2 (8-C), 146.58 (8a-C), 147.36 (2-C), 160.86 (4-C); H (28e) 1.42 (6 H, d, J 7.0, CHMe2), 2.5 (3 H, s, 8-Me), 4.99 (1 H, septet, J 6.8, CHMe2), 7.38 (1 H, m, 6-H), 7.64 (1 H, brd, J 8, 7-H), 7.92 (1 H, m, 5-H), 8.48 (1 H, s, 2-H); C (HSQC / HMBC) (28e) 17.09 (8-Me), 21.53 (CHMe2), 45.99 (CHMe2), 121.3 (4a-C), 123.87 (5-C), 126.42 (6-C), 134.43 (7-C), 135.2 (8-C), 145.85 (8a-C), 144.3 (2-C), 159.63 (4-C); H (49e) 1.41 (6 H, d, J 6.0, CHMe2), 2.5 (3 H, s, 8-Me), 5.43 (1 H, septet, J 6.2, CHMe2), 7.49 (1 H, dd, J 8.0, 7.5, 6-H), 7.73 (1 H, dd, J 7.0, 1.0, 7-H), 7.92 (1 H, brd, J 8.0, 5-H), 8.78 (1 H, s, 2-H); C (HSQC / HMBC) (49e) 16.94 (8-Me), 21.20 (CHMe2), 69.84 (CHMe2), 115.92 (4a-C), 120.75 (5-C), 126.37 (6-C), 133.65 (7-C), 135.5 (8-C), 149.44 (8a-C), 153.31 (2-C), 165.78 (4-C); m/z 203.1178 (28e/49e + H) (C12H15N2O requires 203.1184), 175.0868 (28a + H) (C10H11N2O requires 175.0871), 161.0709 (21a + H) (C9H9N2O requires 161.0715).
Reaction of 10 with 1e
2-Amino-3-methoxybenzamide 10 was treated with 1e, as for the reac​tion of 7 with 1e, to give a colourless oil, which was shown by 1H NMR to comprise 22a, 29a, 8-methoxy-3-(prop-2-yl)​quin​az​ol​in-4-one 29e and 8-methyl-1-(prop-2-yloxy)quinazoline 50e (1.0:2.6:1.4:1.2): H (22a) 3.892 (3 H, s, OMe), 7.35 (1 H, brd, J 8.0, 7-H), 7.45 (1 H, t, J 8.0, 6-H), 7.66 (1 H, dd, J 8.0, 1.0, 5-H), 8.20 (1 H, s, 2-H), 12.2 (1 H, br, 3-H); C (HSQC / HMBC) (22a) 55.85 (OMe), 123.5 (4a-C), 114.89 (5-C), 116.92 (7-C), 127.28 (6-C), 138.00 (8a-C), 147.0 (2-C), 154.4 (8-C), 160.52 (4-C); H (29a) 3.49 (3 H, s, 3-Me), 3.898 (3 H, s, OMe), 7.35 (1 H, brd, J = 8.0 Hz, 7-H), 7.45 (1 H, t, J = 8.0 Hz, 6-H), 7.690 (1 H, dd, J = 8.5, 1.0 H, 5-H), 8.31 (1 H, s, 2-H); C (HSQC / HMBC) (29a) 33.42 (3-Me), 55.91 (OMe), 114.72 (5-C), 116.76 (7-C), 122.50 (4a-C), 127.28 (6-C), 138.66 (8a-C), 147.02 (2-C), 154.46 (8-C), 160.52 (4-C); H (29e) 1.43 (6 H, d, J 6.0, CHMe2), 3.901 (3 H, s, OMe), 4.97 (1 H, septet, J 7.0, CHMe2), 7.35 (1 H, brd, J 8.0, 7-H), 7.45 (1 H, t, J 8.0, 6-H), 7.691 (1 H, dd, J 8.5, 1.0, 5-H), 8.39 (1 H, s, 2-H); C (HSQC / HMBC) (29e) 21.16 (CHMe2), 46.19 (CHMe2), 55.85 (OMe), 116.52 (5-C), 114.89 (7-C), 122.50 (4a-C), 127.28 (6-C), 138.01 (8a-C), 143.90 (2-C), 154.4 (8-C), 159.60 (4-C); H (50e) 1.42 (6 H, d, J 7.0, CHMe2), 3.95 (3 H, s, OMe), 5.55 (1 H, septet, J 6.0, CHMe2), 7.39 (1 H, dd, J 8.0, 1.0, 7-H), 7.56 (1 H, dd, J 8.5, 7.5, 6-H), 7.64 (1 H, dd, J 8.5, 1.2, 5-H), 8.72 (1 H, s, 2-H); C (HSQC / HMBC) (50e) 21.55 (CHMe2), 56.0 (OMe), 69.91 (CHMe2), 112.88 (7-C), 114.09 (5-C), 116.92 (4a-C), 127.53 (6-C), 142.29 (8a-C), 152.92 (2-C), 155.4 (8-C), 165.39 (4-C); m/z 241.0945 (29e/50e + Na) (C12H14N2NaO2 requires 241.0953), 219.1130 (29e/50e + H) (C12H15N2O2 requires 219.1134), 191.0817 (29a + H) (C10H11N2O2 requires 191.0820), 177.1658 (22a + H) (C9H9N2O2 requires 177.0664).
Reaction of 7 with 1f: quinazolin-4-one (19a), 3-(1,1-dimethyl​ethyl)​quinazolin-4-one (26f) and 4-(1,1-dimethyl​ethoxy)​quin​az​oline (47f)
Amide 7 (200 mg, 1.5 mmol) was stirred at 150C with 1g (1.49 g, 7.3 mmol) in dimethylformamide (8.0 mL) for 24 h. Evap​or​at​ion and chromatography (ethyl acetate / petroleum ether 1:4) gave 19a (170 mg, 79%), with data as above. This material (160 mg, 1.1 mmol) was stirred at 150C with 1g (1.49 g, 7.3 mmol) in ethyl acetate (8.0 mL) for 24 h. Evaporation and chromatography (ethyl acetate / pet​r​ol​eum ether 4:1) gave crude 4-(1,1-dimethyl​eth​oxy)quinazoline 26f (3.0 mg, 1.4%) as a colour​less gum: H (COSY / NOESY) 1.75 (9 H, s, But), 7.68 (1 H, ddd, J 8.2, 6.6, 1.5, 6-H), 7.91 (1 H, brd, J 8 Hz, 8-H), 7.94 (1 H, ddd, J 8.4, 6.6, 1.5, 7-H), 8.13 (1 H, ddd, J 8.2, 1.4, 0.6, 5-H), 8.79 (1 H, s, 2-H); C (HSQC / HMBC) 27.84 (Me3), 82.80 (CMe3), 117.00 (4a-C), 123.57 (5-C), 127.19 (6-C), 127.36 (8-C), 133.67 (7-C), 150.49 (8a-C), 153.74 (2-C), 165.65 (4-C); m/z 203.1179 (M + H) (C12H15N2O requires 203.1184). Further elution gave 3-(1,1-di​meth​ylethyl)quinazolin-4-one 47f (21 mg, 9%), as a pale yellow solid: mp 75-78C (lit.4 mp 68-74C); H (COSY / NOESY) 1.74 (9 H, s, But), 7.57 (1 H, ddd, J 8.1, 7.2, 1.2, 6-H), 7.70 (1 H, brd, J 8, 8-H), 7.94 (1 H, ddd, J 8.2, 7.1, 1.6, 7-H), 8.21 (1 H, ddd, J 8.0, 1.5, 0.4, 5-H), 8.47 (1 H, s, 2-H); C (HSQC / HMBC) 27.99 (Me3), 60.47 (CMe3), 122.39 (4a-C), 126.14 (5-C), 126.58 (8-C), 126.75 (6-C), 134.10 (7-C), 145.18 (2-C), 147.20 (8a-C), 161.14 (4-C); m/z 203.1185 (M + H) (C12H15N2O requires 203.1184). Further elution gave recovered 19a (67 mg, 41%), with properties as above.
Reaction of 7 with 1g
2-Aminobenzamide 7 (200 mg, 1.47 mmol) was stirred at 150C with 1g (1.69 g, 7.3 mmol) in dimethylformamide (8.0 mL) for 24 h. Evaporation and chromatography (ethyl acetate / petroleum ether 1:1) gave a colourless gum, which was shown by 1H NMR to comprise 19a and 26a (10:1).
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Figure 1 Structures of orthoamides used in this study.

Scheme 1 Formation of N3-alkylquinazolin-4-ones 26a-d,27a-d,28a-d,29a-d,30a,b,31a,32b by reaction of anthranil​amides 7-12 with 1a‑d. Reagents and conditions: i, SOCl2, NH3; ii, N,N’-carbonyldiimidazole, NH3; iii, 1a, DMF, 150°C; iv, 1b, DMF, 150°C; v, 1c, DMF, 150°C; vi, 1d, DMF, 150°C; vii, 1a, THF, reflux.








Scheme 2 Proposed mechanisms for formation of intermediate quinazolin-4-ones 19-25 and product 3-(primary)​alkyl​quinazolin-4-ones 26-32, demon​st​rating that intermediates 34 (derived from orthoamides 1) can be electrophilic formyl equiv​alents and electro​philic alkylating agents in the same reaction mixture. 
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